Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| Menoufia University | Registry Identifier | Faculty of medicine |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Whether trans muscular QLB provides postoperative analgesia compared with LPB after thigh lift surgery
Adequate analgesia after spiral thigh reduction (thigh lift) is essential for early mobilization and patient satisfaction. Quadratus lumborum block (QLB) has shown analgesic efficacy comparable to lumbar plexus block (LPB) for hip area surgery with potential advantages in motor-sparing and safety
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group QLB | Other | Ultrasound-Guided Trans-muscular QLB |
|
| Group LPB | Other | Ultrasound-Guided Posterior Lumbar Plexus (Psoas Compartment) Block |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Ultrasound-Guided Trans-muscular QLB | Other | With the patient lateral decubitus position, a low-frequency curvilinear probe in the 'Shamrock' view at L2-L4. In-plane posterior-to-anterior needle advancement through the Quadratus lumborum to the interfascial plane anterior to QL and posterior to Psoas major. Inject 30 mL Bupivacaine 0.25% after negative aspiration and hydrodissection to confirm proper spread . Then the patient will be turned to the other side, and the block will be done with the same technique |
| Measure | Description | Time Frame |
|---|---|---|
| Visual analogue scale score | Visual analogue scale score at 1st,6th,12th and 24 h (where 0 is interpreted as no pain, 1-4 mild pain, 5-6 moderate pain, 7-10 severe pain) | 24 hours |
| Measure | Description | Time Frame |
|---|---|---|
| Time for first analgesic request | first analgesic request | 24 hours |
| Opioid consumption | cumulative opioid consumption | 24 hours |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| AMAL G SAFAN, MD | Menoufia University | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Faculty of medicine,Menofia university hospitals | Cairo | Shibin El Kom | 32511 | Egypt |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000377 | Agnosia |
| D010146 | Pain |
| ID | Term |
|---|---|
| D010468 | Perceptual Disorders |
| D019954 | Neurobehavioral Manifestations |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D003766 | Dental Occlusion |
| ID | Term |
|---|---|
| D003813 | Dentistry |
| D009063 | Dental Physiological Phenomena |
| D055688 | Digestive System and Oral Physiological Phenomena |
Not provided
Not provided
Prospective, randomized, parallel-group, double-blind, clinical trial. Primary endpoint: time for first analgesic request postoperatively. Key secondary endpoints: 24-hour opioid consumption (oral morphine equivalents), pain on movement at 6/12/24 hours, time to first ambulation, postoperative nausea/vomiting (PONV), block performance time, and block-related complications. Hypothesis: QLB is non-inferior to LPB for 24-hour pain scores and will yield less motor weakness
Not provided
Not provided
Computer-generated randomization in variable blocks; allocation sealed in opaque envelopes. Blocks performed by an anesthesiologist not involved in postoperative assessment. Patients and outcome assessors are blinded. Drape and opaque dressings conceal injection sites for both groups to preserve blinding
|
| Ultrasound-Guided Posterior Lumbar Plexus (Psoas Compartment) Block | Other | Lateral decubitus, Shamrock view to identify the Psoas compartment; in-plane needle advancement to the Psoas compartment adjacent to the transverse process. Inject 30 mL of Bupivacaine 0.25% in 5 mL increments, aspirating frequently. This will be done in the same position for both sides |
|
| Time to walk >30 (meter) | walk >30 (meter) | 24 hours |
| Performance Time | block performance time | minutes |
| The number of patients who develop block-related complications | nausea and vomiting , hypotension | 24 hours |
| the patients Satisfaction questionnaire | pateints are either : Dissatisfied Neither satisfied nor dissatisfied Satisfied Very satisfied | 24 hours |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |